Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

ABIOMED Inc (ABMD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ABIOMED's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
ABIOMED historical data, for real-time data please try another search
381.02 +0.00    +0.00%
21/12 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 380.51 - 381.28
Type:  Equity
Market:  United States
ABIOMED 381.02 +0.00 +0.00%

ABMD Balance Sheet

 
Featured here, the Balance Sheet for ABIOMED Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2022
30/09
 2022
30/06
 2022
31/03
 2021
31/12
Total Current Assets 1062.8 1060.36 976.47 885.01
Cash and Short Term Investments 820.37 844.32 758.61 669.22
Cash - - - -
Cash & Equivalents 182.34 180.49 132.82 144.26
Short Term Investments 638.04 663.83 625.79 524.97
Total Receivables, Net 94.48 91.1 90.61 88.95
Accounts Receivables - Trade, Net 94.48 91.1 90.61 88.95
Total Inventory 102.24 95.37 93.98 90.2
Prepaid Expenses 45.71 29.56 33.28 36.63
Other Current Assets, Total - - - -
Total Assets 1696.54 1703.64 1673.39 1592.88
Property/Plant/Equipment, Total - Net 202.71 206.84 212.01 205.95
Property/Plant/Equipment, Total - Gross 312.13 312.88 314.07 304.88
Accumulated Depreciation, Total -109.42 -106.04 -102.06 -98.93
Goodwill, Net 72.96 74.86 76.79 77.45
Intangibles, Net 36.83 38.17 39.52 40.28
Long Term Investments 297.28 300.75 351.94 374.17
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - - 10.55 3.68
Other Assets, Total 669.77 690.76 645.83 536.23
Total Current Liabilities 134.06 140.76 138.46 126.8
Accounts Payable 35.07 34.8 35.35 32.07
Payable/Accrued - - - -
Accrued Expenses 67.76 77.1 70.69 64.31
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - 2.89 2.59
Other Current liabilities, Total 31.23 28.87 29.53 27.83
Total Liabilities 156.76 167.44 170.07 159.94
Total Long Term Debt - - 0.489 2.13
Long Term Debt - - 0.489 2.13
Capital Lease Obligations - - - -
Deferred Income Tax 0.689 0.735 0.781 0.799
Minority Interest - - - -
Other Liabilities, Total 22.01 25.94 30.34 30.21
Total Equity 1539.79 1536.2 1503.33 1432.94
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.452 0.456 0.455 0.455
Additional Paid-In Capital 904.76 884.96 870.07 853.21
Retained Earnings (Accumulated Deficit) 1125.2 1019.07 964.51 904.19
Treasury Stock - Common -443.97 -330.02 -304.56 -304.42
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -46.64 -38.27 -27.16 -20.49
Total Liabilities & Shareholders' Equity 1696.54 1703.64 1673.39 1592.88
Total Common Shares Outstanding 45.17 45.57 45.55 45.52
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ABMD Comments

Write your thoughts about ABIOMED Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
kian dan
kian dan Feb 16, 2020 21:30
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This stock is really savage. Best medical company and in a specialized field in their field they are best. Super professional.This company will cross $200 in next year which is almost 20% gain on Abmd.Best price to hop on. it might not be bought on thic price ever again.Rally stock, will hit the sky. BULLISH👍.
Reply
2 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email